LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(9 sites)

Canada

Cumming School of Medicine & Libin Cardiovascular Centre, University of Calgary, Calgary, Alberta

Royal Columbian Hospital, New Westminster, British Columbia

Unity Health Toronto, St. Michael's Hospital, Toronto, Ontario

University Health Network, Toronto General Hospital, Toronto, Ontario

Turkey (Türkiye)

Gazi University, Yenimahalle, Ankara

Kosuyolu High Specialization Training and Research Hospital, Kartal, Istanbul

Erciyes University, Faculty of Medicine - Semiha Kibar Organ Transplant & Dialysis Hospital, Melikgazi, Kayseri

Kocaeli University, Faculty of Medicine Practices and Research Hospital, İzmit, Kocaeli

Sütçü İmam University, Faculty of Medicine, Kahramanmaraş, Onikişubat